ID

15004

Descripción

This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ given at 12-18 mo of age to children primed with either pneumococcal vaccine or Prevenar™ in study 105553. Antibody persistence will be evaluated at 8-14 mo after completion of the 3-dose immunization course in study 105553. The immune response to a booster dose of GSK Biologicals' pneumococcal conjugate vaccine will also be evaluated when given at 12-18 mo to subjects not primed with GSK Biologicals' vaccine but with Prevenar™. The study has 3 groups. 1 group of children primed with GSK Biologicals' pneumococcal conjugate vaccine will receive a booster dose of the same vaccine. 2nd group of children primed with Prevenar™ will receive a booster dose of Prevenar™ (control group). 3rd group of children primed with Prevenar™ will receive a booster dose of GSK Biologicals' pneumococcal conjugate vaccine. All children will receive concomitantly a booster dose of DTPa-HBV-IPV/Hib vaccine. NCT00370396 Part: EXTENDED SAFETY FOLLOW-UP CONTACT

Palabras clave

Versiones (2)
  1. 9/5/16 9/5/16 -
  2. 11/5/16 11/5/16 -
Subido en

11 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Extended safety follow-up contact Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine NCT00370396

Inglés

Extended safety follow-up contact "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 formularios  
Identification
Descripción

Identification

Alias
UMLS CUI-1
C1300638
Center number
Descripción

Center number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0805701
Subject ID
Descripción

Subject ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Treatment Number
Descripción

Treatment Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1522541
Date of birth
Descripción

Date of birth

Tipo de datos

date

Alias
UMLS CUI [1]
C0421451
Gender
Descripción

Gender

Tipo de datos

text

Alias
UMLS CUI [1]
C0079399
Study Conclusion Extended Safety Follow-Up Contact
Descripción

Study Conclusion Extended Safety Follow-Up Contact

Could the subject I subject's parents/guardians be contacted after the end of the active phase?
Descripción

Contract after active Phase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0332522
Date of last contact
Descripción

Date of last contact

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1705415
Has the subject received any other investigational and/or non-registered vaccine and/or drug since the end of the active phase?
Descripción

If yes: GlaxoSmithKline might contact you for further investigation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0042210
UMLS CUI [1,2]
C0949266
Reason for no successive Contract
Descripción

Reason for no successive Contract

Tipo de datos

text

Alias
UMLS CUI [1]
C0332522
Did the subject experience any serious adverse event(s) (SAE(s) since the end of the active phase?
Descripción

If yes,please complete the complete Serious Adverse Event (SAE) report.

Tipo de datos

text

Alias
UMLS CUI [1]
C1519255
Has the subject experienced any meningitis ?
Descripción

Meningitis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025289
Investigator's Signature
Descripción

Investigator's Signature

Alias
UMLS CUI-1
C1519316
UMLS CUI-2
C2826892
Date of Signature
Descripción

Date of Signature

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1519316
UMLS CUI [1,2]
C0011008
Name of Investigator
Descripción

Name of Investigator

Tipo de datos

text

Alias
UMLS CUI [1]
C0008961
Volver a la parte superior de la página

Similar models

Extended safety follow-up contact "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Identification
C1300638 (UMLS CUI-1)
Center number
Item
Center number
text
C1301943 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Treatment Number
Item
Treatment Number
text
C1522541 (UMLS CUI [1])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
text
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (m)
CL Item
Female (f)
Item Group
Study Conclusion Extended Safety Follow-Up Contact
Contract after active Phase
Item
Could the subject I subject's parents/guardians be contacted after the end of the active phase?
boolean
C0332522 (UMLS CUI [1])
Date of last contact
Item
Date of last contact
date
C0011008 (UMLS CUI [1,1])
C1705415 (UMLS CUI [1,2])
Other investigational Vaccines after end of Study
Item
Has the subject received any other investigational and/or non-registered vaccine and/or drug since the end of the active phase?
boolean
C0042210 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Item
Reason for no successive Contract
text
C0332522 (UMLS CUI [1])
Reason for no successive Contract
Code List
Reason for no successive Contract
CL Item
Consent withdrawal (CWS)
CL Item
Lost to follow-up (LFU)
Item
Did the subject experience any serious adverse event(s) (SAE(s) since the end of the active phase?
text
C1519255 (UMLS CUI [1])
SAE after active phase
Code List
Did the subject experience any serious adverse event(s) (SAE(s) since the end of the active phase?
CL Item
No (N)
CL Item
Yes (Y)
CL Item
Subject could not be contacted (NA)
Meningitis
Item
Has the subject experienced any meningitis ?
boolean
C0025289 (UMLS CUI [1])
Item Group
Investigator's Signature
C1519316 (UMLS CUI-1)
C2826892 (UMLS CUI-2)
Date of Signature
Item
Date of Signature
date
C1519316 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial